Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Return on Capital Employed (2016 - 2025)

Xtant Medical Holdings has reported Return on Capital Employed over the past 15 years, most recently at 36.72% for Q4 2025.

  • Quarterly Return on Capital Employed rose 4176.0% to 36.72% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 36.72% through Dec 2025, up 4176.0% year-over-year, with the annual reading at 130.64% for FY2025, 13592.0% up from the prior year.
  • Return on Capital Employed was 36.72% for Q4 2025 at Xtant Medical Holdings, up from 21.62% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 36.72% in Q4 2025 and troughed at 22.02% in Q3 2024.
  • The 5-year median for Return on Capital Employed is 13.62% (2022), against an average of 6.04%.
  • Year-over-year, Return on Capital Employed tumbled -1688bps in 2022 and then soared 4365bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 8.72% in 2021, then plummeted by -80bps to 15.74% in 2022, then grew by 7bps to 14.65% in 2023, then skyrocketed by 66bps to 5.04% in 2024, then soared by 829bps to 36.72% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Return on Capital Employed are 36.72% (Q4 2025), 21.62% (Q3 2025), and 12.58% (Q2 2025).